Middleton v. REGENERON PHARMACEUTICALS, INC.

District Court, S.D. New York

Middleton v. REGENERON PHARMACEUTICALS, INC.

Trial Court Opinion

UNITED STATES DISTRICT COURT SOUTHERN DISTRICT OF NEW YORK MICHAEL I. MIDDLETON,

Plaintiff, ORDER -against-

REGENERON PHARMACEUTICALS, INC., 25-CV-01984 (PMH) Defendant.

PHILIP M. HALPERN, United States District Judge: Plaintiff initiated this action, pro se, on March 6, 2025, but submitted an unsigned complaint. (Doc. 1). By order dated March 13, 2025, the Court directed Plaintiff, within thirty days, to (1) submit a completed request to proceed in forma pauperis or pay the $405.00 in fees required to file a civil action in this court; and (2) sign and submit a signature page, the form of which was attached to the order. (Doc. 4). That order further specified that failure to comply would result in dismissal of the complaint. (Id.). Although Plaintiff paid the fees on April 3, 2025, he did not submit a signature page. Accordingly, the Court dismisses the complaint in this action without prejudice. See Fed. R. Civ. P. 11(a); Becker v. Montgomery,

532 U.S. 757, 764

(2001). The Court certifies under

28 U.S.C. § 1915

(a)(3) that any appeal from this order would not be taken in good faith, and therefore IFP status is denied for the purpose of an appeal. Cf. Coppedge v. United States,

369 U.S. 438, 444-45

(1962) (holding that an appellant demonstrates good faith when he seeks review of a nonfrivolous issue). The Clerk of Court is respectfully requested to close this case. SO ORDERED: Dated: White Plains, New York April 29, 2025 ( i u | PHILIP M. HALPERN United States District Judge

Reference

Status
Unknown